Rankings
▼
Calendar
UTHR FY 2023 Earnings — United Therapeutics Corporation Revenue & Financial Results | Market Cap Arena
UTHR
United Therapeutics Corporation
$24B
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2.3B
+20.2% YoY
Gross Profit
$2.1B
88.9% margin
Operating Income
$1.2B
50.9% margin
Net Income
$985M
42.3% margin
EPS (Diluted)
$19.81
Cash Flow
Operating Cash Flow
$978M
Free Cash Flow
$748M
Stock-Based Comp.
$39M
Balance Sheet
Total Assets
$7.2B
Total Liabilities
$1.2B
Stockholders' Equity
$6.0B
Cash & Equivalents
$1.2B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2.3B
$1.9B
+20.2%
Gross Profit
$2.1B
$1.8B
+15.7%
Operating Income
$1.2B
$980M
+20.9%
Net Income
$985M
$727M
+35.4%
← Q4 2022
All Quarters
Q1 2023 →